Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells.

Lin CC, Yu YL, Shih CC, Liu KJ, Ou KL, Hong LZ, Chen JD, Chu CL.

Cancer Immunol Immunother. 2011 Jul;60(7):1019-27. doi: 10.1007/s00262-011-1016-4. Epub 2011 Apr 17.

PMID:
21499904
2.

Promoting effect of Antrodia camphorata as an immunomodulating adjuvant on the antitumor efficacy of HER-2/neu DNA vaccine.

Huang CH, Chang CC, Lin CM, Wang ST, Wu MT, Li EI, Chang HC, Lin CC.

Cancer Immunol Immunother. 2010 Aug;59(8):1259-72. doi: 10.1007/s00262-010-0852-y.

PMID:
20390417
3.

Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor.

Chen Z, Huang H, Chang T, Carlsen S, Saxena A, Marr R, Xing Z, Xiang J.

Cancer Gene Ther. 2002 Sep;9(9):778-86.

4.

A novel adjuvant Ling Zhi-8 for cancer DNA vaccines.

Chu CL, Chen DzC, Lin CC.

Hum Vaccin. 2011 Nov;7(11):1161-4. doi: 10.4161/hv.7.11.17753. Epub 2011 Nov 1.

PMID:
22048115
5.

Induction of antitumor immunity with combination of HER2/neu DNA vaccine and interleukin 2 gene-modified tumor vaccine.

Chen SA, Tsai MH, Wu FT, Hsiang A, Chen YL, Lei HY, Tzai TS, Leung HW, Jin YT, Hsieh CL, Hwang LH, Lai MD.

Clin Cancer Res. 2000 Nov;6(11):4381-8.

6.

RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency.

Wang ST, Chang CC, Yen MC, Tu CF, Chu CL, Peng YT, Chen DY, Lan JL, Lin CC.

Gene Ther. 2011 Apr;18(4):372-83. doi: 10.1038/gt.2010.146. Epub 2010 Nov 25.

PMID:
21107437
7.

Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine.

Yo YT, Hsu KF, Shieh GS, Lo CW, Chang CC, Wu CL, Shiau AL.

Cancer Gene Ther. 2007 Nov;14(11):904-17. Epub 2007 Aug 17.

PMID:
17704754
8.

In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.

Loskog A, Tötterman TH, Böhle A, Brandau S.

Cancer Gene Ther. 2002 Oct;9(10):846-53.

9.

HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination.

Chan T, Sami A, El-Gayed A, Guo X, Xiang J.

Gene Ther. 2006 Oct;13(19):1391-402. Epub 2006 May 25.

PMID:
16724093
10.

Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice.

Sakai Y, Morrison BJ, Burke JD, Park JM, Terabe M, Janik JE, Forni G, Berzofsky JA, Morris JC.

Cancer Res. 2004 Nov 1;64(21):8022-8.

11.
12.
13.

The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.

Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.

Int J Oncol. 2006 Apr;28(4):947-53.

PMID:
16525645
14.

Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancer.

Kim JH, Majumder N, Lin H, Chen J, Falo LD Jr, You Z.

Mol Ther. 2005 Jun;11(6):941-9.

PMID:
15922965
15.
16.

Autologous neu DNA vaccine can be as effective as xenogenic neu DNA vaccine by altering administration route.

Tu CF, Lin CC, Chen MC, Ko TM, Lin CM, Wang YC, Lai MD.

Vaccine. 2007 Jan 8;25(4):719-28. Epub 2006 Aug 22.

PMID:
16962215
17.

An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways.

Lin YL, Liang YC, Tseng YS, Huang HY, Chou SY, Hseu RS, Huang CT, Chiang BL.

J Leukoc Biol. 2009 Oct;86(4):877-89. doi: 10.1189/jlb.0708441. Epub 2009 Jun 4.

18.

Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.

Okamoto M, Furuichi S, Nishioka Y, Oshikawa T, Tano T, Ahmed SU, Takeda K, Akira S, Ryoma Y, Moriya Y, Saito M, Sone S, Sato M.

Cancer Res. 2004 Aug 1;64(15):5461-70.

19.

Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg.

Huang Y, Chen Z, Jia H, Wu W, Zhong S, Zhou C.

Clin Immunol. 2006 Jun;119(3):280-90. Epub 2006 Mar 10.

PMID:
16531121
20.

Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo.

Wu YG, Wu GZ, Wang L, Zhang YY, Li Z, Li DC.

Med Oncol. 2010 Sep;27(3):736-42. doi: 10.1007/s12032-009-9277-x. Epub 2009 Aug 8.

PMID:
19669608
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk